None
[更多]
This discovery may be used to: Develop a simple blood test to screen Lym-1 reactivity of prospective lymphoma patients for Lym-1 treatment, replacing any need for a biopsy. Develop new antibodies that could be used in either diagnostic assays or therapeutic applications for non-Hodgkin's lymphoma.
[更多]
These features should prove extremely relevant for clinical applications, from cancer to ophthalmology, where increased efficacy and reduce drug toxicity can enhance the therapeutic profile and/or extend patient life for promising and useful drugs.
[更多]
|< <- | [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] | -> >| |